Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Renalytix American Depository Receipt RNLXY

Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Company’s lead product, KidneyIntelX... see more

Recent & Breaking News (OTCQB:RNLXY)

Renalytix to Present at the 2021 Wells Fargo Virtual Healthcare Conference

GlobeNewswire September 3, 2021

Renalytix Appoints Daniel J. Levangie to its Board of Directors

GlobeNewswire August 30, 2021

Payer Budget Impact Analysis Projects Significant Savings from KidneyIntelX(TM) Testing at Primary Care Level

GlobeNewswire August 26, 2021